Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 21, 2016; 22(27): 6095-6099
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6095
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6095
Hepatitis C virus genotypes in Myanmar
Nan Nwe Win, Shingo Nakamoto, Hiroshi Shirasawa, Department of Molecular Virology, Chiba University, Chuo-ku, Chiba 260-8670, Japan
Tatsuo Kanda, Osamu Yokosuka, Department of Gastroenterology and Nephrology, Chiba University, Chuo-ku, Chiba 260-8670, Japan
Author contributions: Win NN and Kanda T performed the research and wrote the paper; Win NN, Kanda T, Nakamoto S, Yokosuka O and Shirasawa H contributed critical revision of the manuscript for important intellectual content.
Conflict-of-interest statement: Tatsuo Kanda reports receiving lecture fees from Chugai Pharmaceutical, MSD, Bristol-Myers Squibb, and Gilead Sciences and receiving grant support from MSD; Osamu Yokosuka reports receiving grant support from Chugai Pharmaceutical, Bayer, MSD, Daiichi-Sankyo, Tanabe-Mitsubishi, Bristol-Myers Squibb, Gilead Sciences and Taiho Pharmaceutical; the other authors have no conflict of interest statement.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Tatsuo Kanda, MD, Department of Gastroenterology and Nephrology, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8677, Japan. kandat-cib@umin.ac.jp
Telephone: +81-43-2262086 Fax: +81-43-2262088
Received: April 14, 2016
Peer-review started: April 18, 2016
First decision: May 12, 2016
Revised: May 23, 2016
Accepted: June 13, 2016
Article in press: June 13, 2016
Published online: July 21, 2016
Processing time: 92 Days and 16.1 Hours
Peer-review started: April 18, 2016
First decision: May 12, 2016
Revised: May 23, 2016
Accepted: June 13, 2016
Article in press: June 13, 2016
Published online: July 21, 2016
Processing time: 92 Days and 16.1 Hours
Core Tip
Core tip: We reviewed the prevalence of hepatitis C virus (HCV) genotypes in Myanmar. HCV genotypes 1, 3 and 6 were observed in volunteer blood donors in and around the Myanmar city of Yangon. Although there are several reports of HCV genotype 6 in Myanmar, the distribution of HCV genotypes has not been well documented in areas other than Yangon. Previous studies showed that treatment with peginterferon and a weight-based dose of ribavirin for 24 or 48 wk could lead to an 80%-100% sustained virological response in Myanmar.